MMADHC
Cobalamin trafficking protein CblD
Also known as: C2orf25, cblD, CL25022, MMAD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3L0
- Gene
- MMADHC
- Ensembl
- ENSG00000168288
- Chromosome
- 2
- Canonical length
- 296 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
Canonical amino-acid sequenceUniProt
296 residues, UniProt reviewed canonical sequence.
>Q9H3L0|MMADHC
1 MANVLCNRAR LVSYLPGFCS LVKRVVNPKA FSTAGSSGSD ESHVAAAPPD ICSRTVWPDE
61 TMGPFGPQDQ RFQLPGNIGF DCHLNGTASQ KKSLVHKTLP DVLAEPLSSE RHEFVMAQYV
121 NEFQGNDAPV EQEINSAETY FESARVECAI QTCPELLRKD FESLFPEVAN GKLMILTVTQ
181 KTKNDMTVWS EEVEIEREVL LEKFINGAKE ICYALRAEGY WADFIDPSSG LAFFGPYTNN
241 TLFETDERYR HLGFSVDDLG CCKVIRHSLW GTHVVVGSIF TNATPDSHIM KKLSGNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MMADHC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 198 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 198 nTPM
- liver: 182 nTPM
- tongue: 175 nTPM
- bone marrow: 136 nTPM
- heart muscle: 107 nTPM
- kidney: 91 nTPM
Single-cell type
- esophageal apical cells: 440 nCPM
- late primary spermatocytes: 366 nCPM
- syncytiotrophoblasts: 289 nCPM
- parietal cells: 230 nCPM
- extravillous trophoblasts: 225 nCPM
- esophageal suprabasal cells: 220 nCPM
Immune cell
- basophil: 184 nTPM
- neutrophil: 151 nTPM
- eosinophil: 130 nTPM
- T-reg: 124 nTPM
- NK-cell: 120 nTPM
- total PBMC: 120 nTPM
Brain region
- choroid plexus: 41 nTPM
- white matter: 36 nTPM
- cerebellum: 34 nTPM
- spinal cord: 34 nTPM
- hypothalamus: 32 nTPM
- cerebral cortex: 32 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MMADHC.
Disease | AllUniProt
Conditions MMADHC is implicated in, by any mechanism.
- Methylmalonic aciduria and homocystinuria, cblD type (MAHCD) MIM:277410
- Homocystinuria-megaloblastic anemia, cblD type (HMAD) MIM:620952
- Methylmalonic aciduria, cblD type (MACD) MIM:620953
Disease | GeneticClinVar
70 pathogenic / likely-pathogenic of 412 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Methylmalonic aciduria and homocystinuria type cblD
- Cobalamin C disease
- Homocystinuria-megaloblastic anemia cblD type
- Isolated methylmalonic aciduria cblD type
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.41
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Methylmalonic aciduria and homocystinuria type D protein
- Methylmalonic aciduria and homocystinuria type D protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MMADHC as an antibody target. Whether an autoantibody or antibody against MMADHC could matter depends on whether native MMADHC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MMADHC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MMADHC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...